Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 1846 AL 1860

A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease

Lee JH, Kim HJ, Kim JU, Yook TH, Kim KH, Lee JY, Yang G.

Int J Mol Sci. 2021 Jan 28;22(3):1324. doi: 10.3390/ijms22031324.

Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia

Parsons C, Lim WY, Loy C, McGuinness B, Passmore P, Ward SA, Hughes C.

Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.

An autopsy case of corticobasal syndrome due to asymmetric degeneration of the motor cortex and substantia nigra with TDP-43 proteinopathy, associated with Alzheimer's disease pathology

Tando S, Kasai T, Mizuta I, Takahashi H, Yaoi T, Saito K, Hojo T, Mizuno T, Hasegawa M, Itoh K.

Neuropathology. 2021 Jun;41(3):214-225. doi: 10.1111/neup.12723. Epub 2021 Feb 3.

Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?

Ritchie DL, Barria MA.

Biomolecules. 2021 Feb 2;11(2):207. doi: 10.3390/biom11020207.

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer's disease from subjective cognitive decline and other dementias

Cicognola C, Hansson O, Scheltens P, Kvartsberg H, Zetterberg H, Teunissen CE, Blennow K.

Alzheimers Res Ther. 2021 Feb 8;13(1):38. doi: 10.1186/s13195-020-00756-6.

Neuropeptides: Roles and Activities as Metal Chelators in Neurodegenerative Diseases

Ben-Shushan S, Miller Y.

J Phys Chem B. 2021 Mar 25;125(11):2796-2811. doi: 10.1021/acs.jpcb.0c11151. Epub 2021 Feb 11.

The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer's disease pathology: From antioxidant to epigenetic therapy

Griñán-Ferré C, Bellver-Sanchis A, Izquierdo V, Corpas R, Roig-Soriano J, Chillón M, Andres-Lacueva C, Somogyvári M, Sőti C, Sanfeliu C, Pallàs M.

Ageing Res Rev. 2021 May;67:101271. doi: 10.1016/j.arr.2021.101271. Epub 2021 Feb 8.

Electrochemical biosensors for biometal-protein interactions in neurodegenerative diseases

Li S, Kerman K.

Biosens Bioelectron. 2021 May 1;179:113035. doi: 10.1016/j.bios.2021.113035. Epub 2021 Jan 26.

Targeting impaired nutrient sensing with repurposed therapeutics to prevent or treat age-related cognitive decline and dementia: A systematic review

Kioussis B, Tuttle CSL, Heard DS, Kennedy BK, Lautenschlager NT, Maier AB.

Ageing Res Rev. 2021 May;67:101302. doi: 10.1016/j.arr.2021.101302. Epub 2021 Feb 17.

The Efficacy of Ketogenic Therapies in the Clinical Management of People with Neurodegenerative Disease: A Systematic Review

Dewsbury LS, Lim CK, Steiner GZ.

Adv Nutr. 2021 Jul 30;12(4):1571-1593. doi: 10.1093/advances/nmaa180.

Region-specific vulnerability in neurodegeneration: lessons from normal ageing

Pandya VA, Patani R.

Ageing Res Rev. 2021 May;67:101311. doi: 10.1016/j.arr.2021.101311. Epub 2021 Feb 24.

Contextual Processing and the Impacts of Aging and Neurodegeneration: A Scoping Review

Tran KH, McDonald AP, D'Arcy RCN, Song X.

Clin Interv Aging. 2021 Feb 24;16:345-361. doi: 10.2147/CIA.S287619. eCollection 2021.

A Scoping Review of Neuromodulation Techniques in Neurodegenerative Diseases: A Useful Tool for Clinical Practice?

Marson F, Lasaponara S, Cavallo M.

Medicina (Kaunas). 2021 Feb 27;57(3):215. doi: 10.3390/medicina57030215.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias